Tufts latest to tap TriNetX as the research network aims to expand globally
Biopharmaceutical companies and contract research organization (CROs) using the TriNetX platform will now be able to identify Tufts Medical Center as a viable research partner, according to the company.
“Tufts Medical Center found TriNetX’s query and analytics capabilities provided them with the ability to dig deeper into its clinical data both to recruit eligible patients into clinical trials and to generate new hypotheses for investigation,” Gadi Lachman, CEO of TriNetX, told Outsourcing-Pharma.com.
The center joins Boston Children’s Hospital as TriNetX’s second healthcare organization member located in downtown Boston. It has 415-beds and brings an additional one million patient lives to TriNetX’s global health research network.
With the onboarding of several new members this year – including Pfizer and Sanofi – Lachman said: “the network is delivering on the benefit of attracting more clinical trials and fostering collaboration.”
“In 2018, we are going to be introducing new offerings to members that enable their PIs to leverage the network’s data for grant-based research, thus further extending the value proposition for healthcare organizations looking to join TriNetX,” he said.
“We are also seeing more international organizations joining,” Lachman added.
TriNetX is currently in 11 countries and is targeting to be in 20 by year-end.